← Back to Search

Virus Therapy

Simplified HCV care within a mobile medical unit for Hepatitis C

N/A

Waitlist Available

Research Sponsored by Family Health Centers of San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months of follow-up

Awards & highlights

Study Summary

This trial will test a simplified approach to delivering HCV care in a street-based mobile medical clinic to see if it is more effective than the current practice of usual care in community clinics.

Eligible Conditions

Hepatitis C

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months of follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months of follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months of follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of patients who initiate HCV treatment

Secondary outcome measures

Initiation rates for medication-assisted treatment (MAT) for Opioid Use Disorder

Number of patients who complete HCV treatment

Number of patients who receive abscess care

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Simplified Care within a Mobile Medical UnitExperimental Treatment1 Intervention

Simplified Care treatment is the same as for Usual Care with the exception that it is taking place within a mobile medical clinic that is scheduled to deliver treatment in alignment with regular syringe exchange services.

Group II: Usual Care within Community ClinicsActive Control1 Intervention

Complete blood count, comprehensive metabolic panel, international normalized ratio, HCV RNA, hepatitis B virus (HBV) serologies, point of care HIV test, and point of care liver fibrosis measurement. HCV genotype if required by patient's insurance for prior authorization. Care for opioid use disorder and skin infection is offered. Completion of the initial visit workup is sufficient to initiate a prior authorization request for DAAs from payers and an appointment for MAT follow-up in a community clinic if indicated. Patient coordination; authorization with insurance companies; scheduling appointments, follow-up, and ancillary support services will be conducted by a Patient Navigator. Patients are seen every 2-4 weeks for monitoring and adherence support. HCV treatment regimens are at the discretion of the treating provider in accordance with AASLD/IDSA guidelines and insurance requirements. Twelve weeks after HCV therapy completion, SVR12 HCV RNA and SVR12 CMP tests will be obtained.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Family Health Centers of San DiegoLead Sponsor

6 Previous Clinical Trials

14,373 Total Patients Enrolled

Media Library

Simplified HCV care within a mobile medical unit (Virus Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04741750 — N/A

Hepatitis C Research Study Groups: Usual Care within Community Clinics, Simplified Care within a Mobile Medical Unit

Hepatitis C Clinical Trial 2023: Simplified HCV care within a mobile medical unit Highlights & Side Effects. Trial Name: NCT04741750 — N/A

Simplified HCV care within a mobile medical unit (Virus Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04741750 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical experiment currently recruiting participants?

"As per information presented on clinicaltrials.gov, this medical trial is not currently recruiting participants; however, the initial posting was made February 2nd 2021 and it underwent its last update March 14th 2022. Although no candidates are sought now, 281 other trials have open enrollment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Increasing HCV Linkage to Care Among People Who Inject Drugs

2021. "Increasing HCV Linkage to Care Among People Who Inject Drugs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04741750.